Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses light and photosensitizing drugs to kill tumor cells and
may be an effective treatment for refractory brain tumors.
PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic
therapy using porfimer sodium in treating patients with refractory brain tumors, including
astrocytoma, ependymoma, and medulloblastoma.